A systematic review found only 8 very small randomized controlled trials testing cannabinoids for mood disorders, anxiety, or PTSD, and concluded there is insufficient evidence to recommend medical cannabis for any of these conditions.
Psychiatrists, medical cannabis prescribers, mental health patients considering cannabis
Only 8 randomized controlled trials exist for cannabinoids in mood disorders, anxiety, or PTSD
What the researchers found
Of 8 identified RCTs, CBD pretreatment showed promise for social anxiety in laboratory settings, but THC showed no benefit for depression and actually worsened anxiety and psychotic symptoms in over 50% of hospitalized depression patients. One small crossover trial found THC reduced PTSD nightmares.
Why it matters
Despite widespread use of cannabis for mental health symptoms, this review reveals that the controlled evidence base is remarkably thin, with only 8 small trials across three major diagnostic categories.
The numbers in context
8 RCTs identified; CBD: 3 studies showed anxiety reduction in social anxiety; THC up to 3 mg/day reduced anxiety in 1 trial but symptoms were already low; THC worsened anxiety/psychotic symptoms in >50% of depression patients; 1 crossover trial of 10 PTSD patients found THC reduced nightmares.
How the study worked
Systematic review searching 8 online databases for randomized controlled trials of defined CBD or THC doses in populations with affective disorders, anxiety disorders, or PTSD.
What this study cannot tell us
Only 8 very small trials identified; heterogeneous designs, doses, and populations; insufficient evidence to draw definitive conclusions about either efficacy or harm.
How to read the evidence
Systematic review revealing a near-total absence of controlled evidence, limiting conclusions despite moderate review quality.
When this study was published
Review published in 2021.
The bigger picture
The mismatch between the large number of people using cannabis for mental health and the tiny number of controlled trials creates a significant evidence gap that leaves both patients and clinicians without reliable guidance.
Questions still open
- Why are there so few controlled trials of cannabinoids for common psychiatric conditions? Would larger, well-designed RCTs reveal benefits that small studies miss?
Common questions
Should I use cannabis for anxiety or depression?
Does cannabis help with PTSD?
Read the original research
Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review.
Psychiatric services (Washington, D.C.), 72(4), 429-436
Citation
Stanciu, Corneliu N; Brunette, Mary F; Teja, Nikhil; Budney, Alan J. (2021). Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review.. Psychiatric services (Washington, D.C.), 72(4), 429-436. https://doi.org/10.1176/appi.ps.202000189
Explore the wider topic
- LGBTQ+ and Cannabis: Higher Use Rates and Recovery
- Cannabis-Induced Psychosis: What It Is, Who's at Risk, and What to Do
- BetterHelp, Cerebral, and Online Therapy: Honest Review
- Quitting Weed with ADHD: Why It Is Harder and What Actually Helps
- Quitting Weed with Depression: What You Need to Know
- Quitting Weed with PTSD: A Practical Guide
- Self-Medicating with Weed: Why It Works Until It Doesn't
- Weed and OCD: Self-Medicating Intrusive Thoughts
- Weed and PTSD: What the Research Actually Shows
- Weed and Childhood Trauma: ACEs, Self-Medication, and the Path to Real Healing
- Weed and Suicidal Thoughts: What You Need to Know